Jnana Therapeutics is a clinical-stage biotechnology company based in Boston, focused on small molecule drug discovery. Utilizing its proprietary RAPID chemoproteomics platform, Jnana aims to address significant medical needs by targeting challenging proteins involved in various diseases, including rare genetic disorders and immune-mediated conditions. The company was acquired by Otsuka Pharmaceut...